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Introduction 1
Skin development and homeostasis requires tightly regulated epidermal keratinocyte proliferation, 2 differentiation and apoptosis, and these processes are governed by cooperation of cis-regulatory 3 elements, transcription factors (TFs), chromatin accessibility as well as higher-order chromatin 4 organisation [1] [2] [3] [4] [5] . The TF p63 is a key regulator of epidermal development. At the molecular level, 5 p63 regulates a large number of genes , for example, p21 (CDKN1A) in cell cycle arrest [6] , Fras1 in 6 maintaining basement membrane integrity [7] and key genes such as keratins, filaggrin, and loricrin 7 required for epidermal morphogenesis and differentiation [1, 8] . Furthermore, p63 directly regulates 8 chromatin factors, Satb1, Lsh, and Brg1, to control the chromatin remodelling during epidermis 9 development [9] [10] [11] . Recent studies showed that p63 exerts a crucial role in establishing the 10 enhancer landscape [4, 5, 12, 13] . Through active enhancers, p63 cooperates with its co-regulating 11
TFs to modulate local transcriptional program required for epidermal homeostasis [4] . 12
In human, heterozygous mutations of TP63 encoding p63 cause a spectrum of ectoderm-related 13 disorders [14] . For example, Ectrodactyly-Ectodermal Dysplasia-Cleft Lip/Palate (EEC) syndrome is 14 caused by point mutations located in the p63 DNA-binding domain, and manifests ectodermal 15 dysplasia with defects in the epidermis and epidermal related appendages, limb malformation and 16 cleft lip/palate. Five hotspot mutations affecting amino acids, R204, R227, R279, R280 and R304, 17 cover approximately 90% of the all EEC syndrome cases [15] . Our previous study showed that 18 mutant p63 resulted in a genome-wide redistribution of enhancers in keratinocytes established from 19 EEC patients [13] . Consistently, the gene network analysis identified a significant co-expression gene 20 module of 'nucleosome assembly', implying a less-organized chromatin structure in EEC syndrome 21 keratinocytes [13] . How mutant p63 affects the chromatin structure is however not yet clear. 22 In this study, we characterized the chromatin accessibility using ATAC-seq in keratinocytes 23 established from EEC patients carrying p63 mutations, in comparison with control keratinocytes. A 24 clear difference in chromatin accessibility that correlated with the transcriptional dynamics was 25 detected. Unexpectedly, strong enrichment of CTCF binding siteswere observed at control-specific 26 open chromatin regions. By combining published promoter Capture Hi-C seq data, we found that 27 CTCF and p63 were cooperatively involved in DNA loops to regulate epidermal genes. Our findings 28 provide new insights into the coordinated regulatory role of CTCF and p63 in chromatin interactions 29 in epidermal keratinocytes. 30 31 Results 1
Differential chromatin accessibility between control and p63 mutant keratinocytes 2
We performed Assay for Transposase-Accessible Chromatin with high-throughput sequencing (ATAC-3 seq) to characterize the accessible genome as well as the nucleosome position in both control and 4 p63 mutant keratinocytes at the proliferation stage. Two replicas of ATAC-seq analyses showed high 5 correlation ( Figure 1A) , indicating high reproducibility. The principle component analysis (PCA) plot 6 based on the chromatin accessibility displayed a clear separation between control and p63 mutant 7 keratinocytes ( Figure 1B) , which is highly consistent with results from gene expression profiles 8 ( Figure 1B) . The PCA analysis also showed that the genome accessibility of the two p63 mutant lines 9 (R204W and R304W) are similar, as they are close on the PC1 axis that represents major variations. 10
As the goal of this work is to examine the difference between control and EEC mutant lines, these 11 two mutant lines were considered as one group, termed as p63 mutant keratinocytes, in the 12 following analyses. 13
Subsequently we identified the differential open chromatin regions (OCRs) marked by ATAC-seq 14 signals between control and p63 mutant keratinocytes. In total, there were 2,492 open chromatin 15 regions that showed higher signal in control keratinocytes, termed as control-specific open 16 chromatin regions (Ctr-OCRs); in parallel, there were 3,716 regions that showed higher signal in 17 mutant keratinocytes, termed as mutant-specific open chromatin regions (Mt-OCRs) ( Figure 1C ). As 18 expected, we found that differential OCRs were positively correlated with gene expression, when 19 they were assigned to the nearest differentially expressed (DE) genes ( Figure 1C ). Genes associated 20 with Ctr-OCRs were mainly involved in the regulation of 'cell cycle' ( Figure 1D ), e.g. CDC7 ( Figure 1E ), 21 while genes nearby Mt-OCRs were mainly enriched in 'actin filament-based process' ( Figure 1D ), e.g. 22 FAP ( Figure 1E ). 23
p63 and CTCF occupancy at Ctr-OCRs 24
To identify the potential TFs involved in these differential OCRs, we first performed a comparative 25 motif analysis between control and p63 mutant keratinocytes using HOMER. Among the Ctr-OCRs, 26
we found that p63 motif is most enriched (Figure 2A ), which is consistent with our previous finding 27 that loss of p63 binding resulted in decreased enhancers in p63 mutant keratinocytes [13] . 28
Unexpectedly, the motif of CTCF that is a well-known genome organizer [16] was identified as the 2 nd 29 highly enriched motif in the Ctr-OCRs. Among the Mt-OCRs, AP-1 motif family was most enriched 30 ( Figure 2B ), consistent with findings on gained enhancers in p63 mutant keratinocytes [13] . 31
To validate our motif analysis result and explore the role of p63 in controlling Ctr-OCRs, we used 1 published p63 ChIP-seq data from our previous work [13] . In control keratinocytes, a total of 1,223 2 p63 binding sites (BSs) were covered by the 2,492 Ctr-OCRs, showing a significant overlap (p < 0.001). 3
When ATAC-seq and p63 ChIP-seq reads were mapped to the 1,223 p63-bound Ctr-OCRs, we found a 4 decrease of both chromatin accessibility and p63 binding signals at the p63-bound Ctr-OCRs in p63 5 mutant keratinocytes ( Figure 2C ). 6
To confirm the role of CTCF in Ctr-OCRs, we performed CTCF ChIP-seq in both control and p63 7 mutant keratinocytes. In total, we found 12,116 CTCF BSs, among which only 363 were differential in 8 CTCF binding between control and p63 mutant keratinocytes (p < 0.05), indicating that CTCF binding 9 is rather stable. In addition, among all putative CTCF BSs, we found 376 overlapped with the 2,492 10 Ctr-OCRs, which is statistically significant (p < 0.001). We then mapped ATAC-seq and CTCF ChIP-seq 11 reads to the 376 CTCF-bound Ctr-OCRs. As expected, decrease of ATAC-seq signals was observed at 12 the CTCF-bound Ctr-OCRs in p63 mutant keratinocytes. However, unexpectedly, there was no 13 significant change in CTCF binding signals at the CTCF-bound Ctr-OCRs in p63 mutant keratinocytes, 14 as compared to the control keratinocytes ( Figure 2D ). Another expected finding was that there is few 15 overlap (N=435) out of 45,350 p63 BSs and 12,116 CTCF BSs (Supplementary Figure 1A) , although 16 both motifs were identified in Ctr-OCRs. Consistently, there was no visible CTCF binding signal at all 17 p63 BSs, and vice versa, no visible p63 binding at the CTCF BSs (Supplementary Figure 1B) . 18
Consistently, we also observed decreased p63 binding and largely unchanged CTCF binding signal in 19 p63 mutant keratinocytes at the co-localized binding sites (Supplementary Figure 1C) . 20
Subsequently, we analyzed the nucleosome positioning at p63-bound and CTCF-bound Ctr-OCRs by 21 mapping the distribution of ATAC-seq fragments centered on either p63 motif or CTCF motif ( Figure  22 2E). In control keratinocytes, we found an enrichment of short fragments (< 150 bp) surrounding 23 both p63 motif and CTCF motif. The enrichment of such short reads clearly decreased in p63 mutant 24 keratinocytes ( Figure 2E and Supplementary Figure 2 ). We also observed an enrichment of 25 fragments that had lengths slightly shorter than 200 bp which represent the stable flanking 26 nucleosomes in control keratinocytes. However, in p63 mutant keratinocytes, the approximate 200 27 bp length-fragments seemed to be less present ( Supplementary Figure 2) , indicating an altered 28 nucleosome organization. 29
Taken together, we observed decreased accessibility at p63-bound and CTCF-bound Ctr-OCRs in p63 30 mutant keratinocytes when compared to control keratinocytes. Notably, there was a clear decrease 31 of p63 binding at the p63-bound Ctr-OCRs whereas CTCF binding did not seem to be affected at the 32 CTCF-bound Ctr-OCRs in p63 mutant keratinocytes. 33
Characterization of p63-bound OCRs and CTCF-bound OCRs 1
We reasoned that the chromatin states and the genomic locations of these Ctr-OCRs might be 2 informative to understand the difference between p63-bound and CTCF-bound Ctr-OCRs. To this 3 end, we firstly analyzed the chromatin states (CSs) of all CTCF and p63 BSs with the combination of 4 six histone marks from Roadmap project [17] ( Figure 3A ). We found that p63 bound to both 5 promoters and enhancers marked by H3K27ac and H3K4me1, whereas CTCF was more enriched at 6 promoters marked by H3K4me3 ( Figure 3A and Supplementary Figure 3 ). We then performed 7 analyses on the p63-and CTCF-bound Ctr-OCRs ( Figure 3B ). When comparing to all Ctr-OCRs, p63-8 bound Ctr-OCRs were overrepresented at enhancers (CSs 8, 9, and 11) while the majority of CTCF-9
bound Ctr-OCRs showed overrepresentation at promoter proximal regions (CSs 2 and 4, Figure 3B ), 10 consistent with all p63 and CTCF BSs. 11
Next, to analyze the localization of p63-bound and CTCF-bound Ctr-OCRs in regulatory chromatin 12 interactions, we utilized the Promoter Capture Hi-C (PCHiC) data and TAD (topologically associating 13 domain) regions from published HiC data in keratinocytes [18] . In the PCHiC, promoters were used 14 as baits to capture the interacting genomic regions. In total, this PCHiC dataset captured 119,648 15 interactions, including 103,497 (86.5%) promoter-enhancer loops and 16,151 (13.5%) promoter-16 promoter loops ( Figure 3C ). As p63 plays a more prominent role at enhancers ( Figure 3A) [4], we 17 focused on promoter-enhancer loops. These loops had a median loop size of 250.9 kb ( Figure 3D ). 18
Among the previously defined 1,223 p63-bound Ctr-OCRs ( Figure 2C ), 388 of them were located at 19 the anchors of 1,674 loops, at either the promoter or the enhancer, and on average one p63-bound 20
Ctr-OCR was connected by ~4.3 loops. Similarly, among the 376 CTCF-bound Ctr-OCRs ( Figure 2D ), 21 191 of them were located at the anchors of 1,093 loops; on average, one CTCF-bound Ctr-OCR was 22 connected by ~5.7 loops. Therefore, CTCF-bound Ctr-OCRs at anchors were connected by more loops. 23 Furthermore, we found that CTCF-bound Ctr-OCRs located at loop anchors were more enriched for 24 promoters (~ 4 fold) ( Figure 3E ), consistent with all CTCF BSs and all CTCF Ctr-OCRs. In contrast, p63-25 bound Ctr-OCRs associated with loops were enriched in both promoters and enhancers to a similar 26 extent ( Figure 3E ), which is different from all p63 BSs and all p63-bound Ctr-OCRs that were only 27 enriched at enhancers ( Figure 3B ). We also examined whether p63-and CTCF-bound Ctr-OCRs were 28 localized at the TAD boundaries. As expected, CTCF-bound Ctr-OCRs showed ~2.5 fold enrichment 29 for TAD boundaries, whereas p63-bound Ctr-OCRs were depleted of TAD boundaries ( Figure 3E ). 30
Randomization by reshuffling genomic regions with same sizes did not show any enrichment in TAD 31 boundaries, promoters or enhancers. As CTCF-bound Ctr-OCRs were enriched at the promoters and 32 p63-bound Ctr-OCRs were enriched at both promoters and enhancers, it is plausible that p63-bound 33 enhancers interact with CTCF-bound promoters to regulate genes through DNA looping and a subset 1 of these loops may be affected by p63 mutations. 2 p63 and CTCF mediate a subset of loops to regulate transcription 3
To assess how p63 and CTCF cooperates via DNA looping to regulate gene expression, we performed 4 further analyses using previously published gene expression data [13] to examine the relation 5 between gene expression and DNA looping. In control keratinocytes, we defined highly expressed 6 genes by quartiles to four groups using their transcriptional levels (Q1-4, FPKM ≥ 1), and another 7 group with lowly expressed genes (Q0, FPKM < 1). We detected an increasing number of associated 8 loops with elevated gene expression levels ( Figure 4A ). This suggests that highly expressed genes 9 may be more indispensable of regulation through loops, which is line with previous study showing 10 multi-loop activation hubs at key regulatory genes [19] . Moreover, the differentially expressed genes 11 between control and p63 mutant keratinocytes ( Figure 1B) were associated with significantly more 12 loops (p < 0.001) than all expressed genes ( Figure 4B ). We also performed the same analysis among 13 loops with either p63-bound or CTCF-bound Ctr-OCRs. Similar results were found, although in these 14 comparisons the difference was not significant, probably due to the low number of associated loops 15 (Figures 4C and D) . 16 We then mapped 388 p63-bound and 191 CTCF-bound Ctr-OCRs which are located at loop anchors 17 to their target genes by identifying their interacting gene promoters located at anchors of the other 18 end of the loops. In some cases, Ctr-OCRs were located in promoters, and the associated genes were 19 considered as target genes. In total, 388 p63-bound Ctr-OCRs interacted with 304 gene promoters 20 while 191 CTCF-bound Ctr-OCRs interacted with 500 gene promoters through looping interactions, 21
indicating that on average a CTCF-bound Ctr-OCR is involved in the regulation of more genes than a 22 p63-bound Ctr-OCR. There was a significant (p < 0.001) overlap (N = 96) of genes that were 23 potentially regulated by p63-and CTCF-bound Ctr-OCRs ( Figure 4E ). These 96 genes represent genes 24 connected by the promoter-enhancer loops that were anchored by both p63-bound and CTCF-bound 25
Ctr-OCRs and that may be affected in p63 mutant keratinocytes. As the three-dimensional chromatin 26 landscape is relatively stable, we reasoned that the difference of the chromatin landscape in control 27 and p63 mutant keratinocytes may influence gene expression during keratinocyte differentiation 28 [18] . Therefore, we examined the expression of these 96 genes using previously reported differential 29 gene expression in control and p63 mutant keratinocytes during differentiation [13] . Indeed we 30 found that 39 of these 96 genes showed deregulation (p < 0.001). Notably many of the 96 genes 31 were involved in 'epidermal cell differentiation', e.g. KRT5, KRT75, and B9D1 ( Figure 4F ). 32
Next, we dissected how p63-bound and CTCF-bound Ctr-OCRs at loop anchors co-regulated these 96 1 genes: whether p63-bound and CTCF-bound Ctr-OCRs were involved in the same or different 2 promoter-enhancer loops. We found that 60 genes were regulated by promoter-enhancer loops 3 where p63-bound and CTCF-bound Ctr-OCRs were both located at the anchors in the same loops, 4 although they may co-localized in different manner ( Figure 4G ). Among these 60 genes, 26 showed 5 differential expression between control and p63 mutant keratinocytes during differentiation, with 6 PIGV and KRT5 shown as examples ( Figures 4I and J) . Among the loops associated with the 60 genes, 7 the case where p63-bound Ctr-OCR was located at one anchor while CTCF-bound Ctr-OCR was 8 located at the other anchor of the loop counted for 12.6% ( Figure 4G, (1) ). In the majority of the 9 cases, both p63-bound and CTCF-bound Ctr-OCRs were present either at the promoter (70.6%) 10 ( Figure 4G , (2)) or at the enhancer (16.8%) ( Figure 4G, (3) ). Interestingly, for the rest 36 genes gene 11 promoters were connected with both p63-bound and CTCF-bound Ctr-OCRs from different loops 12 ( Figure 4H ), suggesting that enhancers occupied by p63-bound and CTCF-bound Ctr-OCRs can co-13 regulate the same gene through different loops. Among these 36 genes, 13 were deregulated in p63 14 mutant keratinocytes during differentiation. 15
16
Discussion 1 Over the years, molecular understanding of p63 function in keratinocytes has led to the 2 identification of numerous target genes including chromatin factors [20] [21] [22] as well as of a solid role 3 of p63 in orchestrating the enhancer landscape [4, 5, 23] . However, whether p63 is involved in the 4 direct regulation of chromatin architecture is not known. In this study, we characterized the 5 chromatin accessibility with ATAC-seq in both control and EEC syndrome patient keratinocytes 6 carrying p63 mutations (R204W and R304W). Interestingly, we found decreased chromatin 7 accessibility in p63-and CTCF-bound open chromatin regions in mutant p63 keratinocytes. These 8 less accessible chromatin regions interact with epidermal gene promoters and potentially regulate 9 gene expression. Collectively, we proposed an unreported role of p63 directly cooperating with CTCF 10 in chromatin interactions. 11
It is envisaged that p63 is a key factor in skin keratinocytes [4, 5, 24] . Ample studies have shown that 12 the proper regulation of gene expression by p63 through the precise control of enhancers is 13 essential for maintaining the epidermal cell identity [4, 13, 25, 26] . It is equally important that p63 14 requires additional co-regulating TFs to regulate transcription. Several studies reported p63 co-15 regulating TFs, e.g. AP1, AP2, STAT5, and RFX5 [20, 22, 23, 27] , which are essential for the epidermal 16 gene expression in a temporal and spatial manner [4, 28] . Besides, p63 interacts with the chromatin 17 remodelling factor BAF1 to maintain the open chromatin regions [5] and with Dnmt3a to locate 18 enhancers [12] . In this study, we found that CTCF, a well-known TF maintaining the chromatin 19 architecture, is also a p63 co-regulating TF modulating a subset of chromatin loops. However, this 20 cooperation is probably not through direction protein-protein interactions but mainly bridging 21 enhancers and promoters, given the few overlap observed between p63 and CTCF BSs. It is known 22 that the majority of p63-bound regions are located in intergenic or intragenic regions (enhancers) 23 rather than promoters [22] , and therefore how p63-bound enhancers interact with gene promoters 24 is an interesting question. Our current study provides the first line of evidence that the cooperation 25 with CTCF assists the looping of p63-bound enhancers to gene promoters. 26
The observation of the enriched CTCF motif in Ctr-OCRs detected in our ATAC-seq analyses was 27 somewhat unexpected. Our previous enhancer-centred analysis that focused on H3K27ac enriched 28 genomic regions did not capture CTCF motifs [4, 13] , probably due to the fact that CTCF is more 29 enriched in open chromatin regions depleted of H3K27ac but enriched for H3K4me3 signal ( Figure  30 3A and Supplementary Figure 3) . Interestingly, detecting the CTCF motif in Ctr-OCRs in keratinocytes 31 is in line with the previous finding that the motif of YY1 was enriched in p63-bound sequences [27] . 32 YY1 has been shown to co-localize with CTCF and stabilize chromatin looping [29, 30] . 33 CTCF maintains the genome organization by occupying the boundaries of megabase-scale TADs, and 1 functions as an insulator to block enhancer-promoter interactions between different TADs [16] . Our 2 date showed that, in addition to demarcating TADs, CTCF mediates promoter-enhancer loops, often 3 located in promoter-proximal regions ( Figure 3E ), to facilitate the promoter-enhancer interactions 4 within one TAD. This is in line with the concept that a subpopulation of CTCF associates with the RNA 5 polymerase II (Pol II) protein complex to activate transcription [31] . It is likely that CTCF helps to 6 bridge the p63-bound enhancers to transcription start site-proximal regulatory elements and to 7 initiate transcription by interacting with Pol II, thus supporting a role of CTCF in facilitating contacts 8 between transcription regulatory sequences. This model has been demonstrated by the previous 9 work on the beta-globin locus [32] . To get a clearer picture, technologies that are similar to ChIA-PET 10
[33], such as HiChIP [34] , would be useful to understand long-range contacts associated with CTCF or 11 p63 in skin keratinocytes. 12
The three-dimensional chromatin landscape is relatively stable once established in a specific cell 13 type, probably during cell commitment, and cell-type-specific looping structures mainly control the 14 accessibility of enhancers to their specific targets [35] . Recent studies showed that cell type-specific 15
TFs are involved in regulation of DNA looping in macrophage development, which shed light on the 16 role of cell type-specific TFs in regulating chromatin interactions [19] . Here we proposed that a 17 number of loci nearby epidermal genes were organized into a 'regulatory chromatin hub' within the 18 chromatin interactions mediated by CTCF in epidermal keratinocytes ( Figure 5A ). Such hubs contain 19 multiple connecting DNA loops that require not only CTCF binding that is rather static but also 20 binding of cell type-specific TFs (e.g. p63) for the transcriptional activity. In this model, cell type-21 specific TFs may be essential to make the DNA loops active in transcription. This hypothesis is 22 consistent with our observation that unchanged CTCF binding signal but decreased accessibility in 23 the CTCF-bound Ctr-OCRs in p63 mutant keratinocytes ( Figure 2D ). 24
Moreover, our observations shed light on the chromatin-based mechanisms underlying EEC 25 syndrome caused p63 mutations. These EEC mutations, such as R204W and R304W, were shown to 26 disrupt p63 DNA binding, resulting in impaired transactivation activity and loss of epidermal cell 27 identity [13, 36, 37] . Our data suggest that deregulated function of DNA loops mediated by p63 and 28 CTCF represents an additional layer to the disease mechanism ( Figure 5B ). Given that CTCF binding 29 did not change, it is likely that the looping interactions are static, but the looping is no longer active 30 due to the absence of p63 binding ( Figure 5B (1) ). Therefore, the epidermal genes were down-31 regulated and p63 mutant keratinocytes showed loss of epidermal cell identity [13] . On the other 32 hand, it is also possible that the loop ablation as a result of lost p63 binding leads to the decreased 33 accessibility at CTCF-bound promoters and deregulated gene expression in p63 mutant keratinocytes 1 ( Figure 5B (2) ). The latter scenario suggests p63 is the key factor determining the regulatory activity 2 of such promoter-enhancer interactions. Nevertheless, how p63 mutations affect the cooperation 3 between p63 and CTCF and gene expression is still unclear. Among the 96 genes with loops 4 connected by p63-and CTCF-bound Ctr-OCRs, only 39 of them were deregulated in p63 mutant 5 keratinocytes. It is possible that 'shadow enhancers' that are composed of clusters of enhancer and 6 contribute to robust gene transcription [38, 39] , are involved in regulation of the 57 genes that are 7 not deregulated in mutant keratinocytes. Further experiments are required to test these hypotheses. 8
Taken together, our results highlight the cooperation of p63 and CTCF in mediating DNA loops as 9 well as gene regulation. These observations provide new insights into the general regulatory role of 10 chromatin looping which depends on the coordination of CTCF and cell type-specific TFs such as p63 11 in skin keratinocytes. 12
13
Material and methods 1
Ethics statement 2
All procedures for establishing and maintaining human primary keratinocytes were approved by the 3 ethical committee of the Radboud university medical center ("Commissie Mensgebonden Onderzoek 4 Arnhem-Nijmegen"). Informed consent was obtained from all donors of a skin biopsy. 5
Human primary keratinocyte culture 6 Primary keratinocytes were established previously from skin biopsies of three EEC syndrome 7 patients carrying heterozygous mutations in the p63 DNA-binding domain, R204W[40] and R304W 8
[37], as well as of non-EEC volunteers (Dombi23, referred to as control) [41] . R204W and R304W are 9 treated as a p63 mutant group for further analyses to minimize the effect from individual difference. 10
As previously described [42] , primary keratinocytes were cultured in Keratinocyte Basal Medium 11 (KBM, Lonza #CC-4131) supplemented with 100 U/mL Penicillin/Streptomycin (Gibco Life Technology 12 #15140122), 0.1 mM ethanolamine (Sigma Aldrich #141-43-5), 0.1 mM O-phosphoethanolamine 13 (Sigma Aldrich #1071-23-4), 0.4% (vol/vol) bovine pituitary extract, 0.5 μg/mL hydrocortisone, 5 14 μg/mL insulin and 10 ng/mL epidermal growth factor (Lonza #CC-4131). Medium was refreshed 15 every other day. When cells were more than 90% confluent, cells were collected at the proliferation 16 stage. No mycoplasma contamination is found during cell culture. 17
ATAC-seq 18
ATAC libraries of the control and p63 mutant keratinocytes were prepared by a documented 19 protocol [43] . In brief, keratinocytes were treated with Accutase® solution on plates and well re-20 suspended into single cells. Pellet cells for 5 min at 500 g. After twice wash with ice-old PBS, pellet 21 the cells again. Re-suspend cells and take out 100,000 cells for lysis with ice-old freshly made lysis 22 buffer (containing 10 mM Tris-HCl pH 7.5, 10 mM NaCl, 3 mM MgCl 2 and 0.1% IGEPAL CA-630 23 detergent). Then perform tagmentation using 2 μl of Tn5 transposase and 12.5 ul 2 × TD buffer 24 (Illumina #FC-121-1031) at 37°C for 1h with 650 rpm shaking. The resulted DNA fragments 25 underwent two sequential seven-cycle PCR amplification, and in between the libraries were selected 26 for <500 bp fragments using SPRI beads. The final PCR products were purified with QIAquick PCR 27
Purification Kit (QIAGEN #28106) and quantified with the KAPA Library Quantification Kit (Kapa 28 Biosystems #KK4844), and then sequenced in a paired-ended manner using the NextSeq 500 29 (Illumina) according to standard Illumina protocols. 30
CTCF ChIP-seq 31
Chromatin for ChIP was prepared as previously described [20] . ChIP assays were performed 1 following a standard protocol [44] with minor modifications. On average, 0.5M keratinocytes were 2 used in each ChIP. 4x ChIP reactions are pooled to prepare one ChIP-seq sample. Antibodies against 3 CTCF (Millipore #07-729, 5ul) was used in each ChIP assay. Resulted DNA fragments from four 4 independent ChIP assays were purified with QIAquick PCR Purification Kit (QIAGEN #28106). 5
Afterwards, 5 ng DNA fragments were pooled and proceeded on with library construction using 6 KAPA Hyper Prep Kit (Kapa Biosystems #KK8504) according to the standard protocol. The prepared 7 libraries were then sequenced using the NextSeq 500 (Illumina) according to standard Illumina 8 protocols. 9
RNA-seq data analysis 10
Paired-end RNA-seq reads were mapped to the human genome hg19 using STAR aligner[45] in two-11 pass mode with default parameters, and enumerate stranded gene-level read counts at the same 12 time. The generated count matrix was used as input for DESeq2 package [46] to distinguish 13 differential expressed genes between control and mutant keratinocytes. These genes greater than 14 1.5-fold changed at adjusted p value < 0.05 were considered significantly deregulated. 15
ChIP-seq and ATAC-seq data analysis 16
Sequenced reads were aligned against the UCSC hg19 human reference genome with Burrows-17
Wheeler Aligner (BWA) program with default parameters [47] . The potential PCR and optical 18 duplicates were removed using Picard MarkDuplicates option. The filtered BAM files were inputted 19 to MACS2 [48] for peak calling. The p63 ChIP-seq data was published and re-analyzed in this study 20 [13] . The p63, CTCF and H3K27ac were called using the narrow setting (default) with a q-value of 21 0.01. For ATAC-seq, the open chromatin regions were predicted using default parameters except for 22 using -f BAMPE option. Peaks overlapping with the consensus excludable ENCODE blacklist were 23 dropped to avoid confounding by repetitive regions. All alignment files were extended to 200-bp and 24 scaled to RPKM-normalized read coverage files using deepTools [49] for visualization. To compare 25 binding profiles between different samples unbiasedly, we applied library size factors estimated 26 from DESeq2 [46] on RPKM values. 27
Differentially accessible regions were detected using DESeq2 package [46] with fold change less than 28 2.0 and p-value below 0.05. Differential motif analysis in the differential DHSs was employed by the 29 findMotifs function in HOMER tool (http://homer.salk.edu/homer/motif/) with other default 30 parameters, which can normalize the background sequences to remove GC-bias. The BEDtools suite 31 (https://bedtools.readthedocs.io/en/latest/content/bedtools-suite.html) was used to test overlap 1 and enrichment between different intervals. 2
Dimensionality reduction and functional annotation 3
For visualization, top 1,000 variable genes were first selected based on interquartile range (IQR) of 4 normalized expression values, and further used to reduce dimensionality (principal component 5 analysis) of the dataset by pca function in R. Functional enrichment was evaluated by Metascape 6 online tool [50] , to gain insight into the biological functions for deregulated genes. Only these 7 functional terms with Benjamini-adjusted p-value < 0.05 were considered significantly 8 overrepresented. 9
Capture Hi-C data processing 10 Raw Promoter Capture Hi-C sequencing reads from GSE84662 were processed using the HiCUP 11 pipeline [51], like quality control, alignment to hg19 and reads filtering. Technical replicates were 12 merged and de-duplicated, and then pooled biological replicates was then jointly used for 13
interaction identification with CHiCAGO [52] and the associated chicagoTools suite. All significant 14 interactions were defined based on a strict interaction threshold (CHiCAGO score ≥ 5). We thank Eva Janssen-Megens, Siebe van Genesen and Rita Bylsma for operating the Illumina 5 analyzer. We thank the ENCODE Consortium for sharing their data. 6
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To review our complete dataset GEO accession GSE123711 10 the randomized sequences. The 18 CSs were defined using ENCODE data [17] . 4 B. Relative enrichment (> 1)/depletion (< 1) of CSs in p63-bound Ctr-OCRs and CTCF-bound Ctr-5
OCRs compared to all Ctr-OCRs. The circle size represents the percentage of either p63-6
bound Ctr-OCRs (left) or CTCF-bound Ctr-OCRs (right) in each CS. Relative score is calculated 7 by comparing odds ratios between two overlap tests, in which odds ratio is estimated by 8
BEDtools fisher option. 9 C. Percentage of different loop types defined in the PCHiC data. 10 D. Size distribution of promoter-enhancer loops in the PCHiC data. 11 E. Estimated enrichment of CTCF and p63 at promoters, enhancers, or TAD Boundary 12 compared to the reshuffled sequences (CTR). Odds ratio indicates the enrichment (> 13 1)/depletion (< 1) of two independent peak lists calculated by BEDtools fisher option. genes. ***, p < 0.001, Wilcoxon signed-rank test. 8 C. DE genes were associated with more connected DNA loops with p63-bound Ctr-OCRs when 9 compared to all expressed genes. 10 D. DE genes were associated with more connected DNA loops with CTCF-bound Ctr-OCRs when 1 compared to all expressed genes. 2 E. Overlapping of genes mapped by CTCF-bound Ctr-OCRs (orange) and p63-bound Ctr-OCRs 3 (blue). 4 F. GO annotation of the 96 genes potentially co-regulated by p63 and CTCF. 5 G. p63-bound and CTCF-bound Ctr-OCRs were involved in the same or different loops 6 connecting the promoters of the 96 genes. 60 genes were regulated by the same loops with 7 both p63-bound and CTCF-bound Ctr-OCRs: (1) in 12.6% cases, p63-bound Ctr-OCR located 8 at one anchor while CTCF-bound Ctr-OCR located at the other anchor of the loop; in the 9 majority cases, p63-bound and CTCF-bound Ctr-OCRs were both present at the (2) A. In control keratinocytes, p63 and CTCF co-mediate a subset of DNA loops nearby epidermal 3 genes and regulate their gene expression. 4 B. In p63 mutant keratinocytes, due to the loss of p63 binding, p63 and CTCF co-mediated DNA 5
loops are not functional anymore, and therefore epidermal genes are deregulated. There are 6 two possibilities in deregulated function of looping: (1) the looping structure is stable as 7 CTCF binding is unchanged; (2) the looping structure is partially changed because of loss of 8 p63 binding and loss of the p63-dependent loop. 9 10 11
